- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on May 18, 2026
B-LH706-AE47LH Luteinizing Hormone (CLIA) is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by Hangzhou Aichek Medical Technology Co., Ltd.. Placed on the EU market in Spain. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
D-LH706-AE47B-LH706-AE47LH706-AE10Y, LH706-AE10N, LH706-AE20Y, LH706-AE20ND-LH706-AE47
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0102050105LUTEINISING HORMONE1 warning recorded — scroll inside the panel to see all entries.
CW010No certificate specifically references this device's Basic UDI-DI.
Primary placement in Spain; available across 1 country total.
| Country | On market since | Until |
|---|---|---|
| SpainPrimary placement | Still on market |
CN-MF-000028093No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.B-5-NT601DROn the market6-MAM One Step 6-Monoacetylmorphine TestB-6-MAM-A01a3ROn the marketA-TG Antibody to Thyroglobulin (CLIA)B-ATG706-AEV9On the marketA-TPO Antibody to Thyroid Peroxidase (CLIA)B-ATPO706-AE79On the marketAdenosine Deaminase Reagent KitB-ADA6014BOn the market